Clinical trial
Influence of Sarcopenia on Mortality and Disease Progression in Hepatocellular Carcinoma Treated With Ablation, Embolization and Sorafenib
NCT06177496 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Sarcopenia on Mortality and Disease Progression in Hepatocellular Carcinoma Treated With Ablation, Embolization and Sorafenib
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2024
- Completion date
- December 1, 2024
- Enrollment
- 600 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.